Form 8-K - Current report:
SEC Accession No. 0001493152-25-019095
Filing Date
2025-10-23
Accepted
2025-10-23 16:30:50
Documents
15
Period of Report
2025-10-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 56601
2 EX-3.1 ex3-1.htm EX-3.1 11921
3 EX-99.1 ex99-1.htm EX-99.1 16736
4 GRAPHIC ex99-1_001.jpg GRAPHIC 4130
  Complete submission text file 0001493152-25-019095.txt   272768

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20251022.xsd EX-101.SCH 3011
6 XBRL LABEL FILE envb-20251022_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE envb-20251022_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3958
Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 251413463
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)